The Precision Peptide Company Inc. PNGAF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.28M | -416.70K | -1.01M | -2.45M | -477.00K |
| Total Depreciation and Amortization | -- | -- | -- | 33.30K | 32.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 474.60K | 44.10K | 557.50K | 1.65M | 30.60K |
| Change in Net Operating Assets | -449.30K | -257.10K | 32.20K | -347.80K | 111.60K |
| Cash from Operations | -1.25M | -629.70K | -420.80K | -1.12M | -302.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 89.50K | -51.10K | 51.20K | 290.00K | -28.60K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -72.80K |
| Cash from Investing | 89.50K | -51.10K | 51.20K | 290.00K | -101.40K |
| Total Debt Issued | -- | -- | -- | 100.00K | -- |
| Total Debt Repaid | -- | -- | -- | -17.80K | -1.00K |
| Issuance of Common Stock | 2.65M | 1.30M | 20.00K | 181.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -475.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 5.00K | 2.72M |
| Cash from Financing | 1.90M | 947.80K | 14.40K | 193.30K | 1.63M |
| Foreign Exchange rate Adjustments | -34.20K | -4.90K | -38.80K | 11.40K | -5.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 702.50K | 262.10K | -393.90K | -621.00K | 1.22M |